Author

Ben Y. Zhang

Institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Mayo Clinic Comprehensive Cancer Center (Minnesota)

Observed institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5017357488

Non-V600BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal Cancer

2017 · Jeremy C. Jones, Lindsay A. Renfro, et al. · Journal of Clinical Oncology · 339

A novel prognostic model for patients with sarcomatoid renal cell carcinoma

2014 · Ben Y. Zhang, R. Houston Thompson, et al. · British Journal of Urology · 97

Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer

2016 · Ben Y. Zhang, Jeremy C. Jones, et al. · Clinical Colorectal Cancer · 48

Carbonic anhydrase IX ( CAIX ) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma ( ccRCC ) after long‐term follow‐up

2013 · Ben Y. Zhang, R. Houston Thompson, et al. · British Journal of Urology · 44

Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma

2015 · Ben Y. Zhang, John C. Cheville, et al. · European Urology · 39

Impact of BRAF mutation and BRAF inhibition on melanoma brain metastases

2014 · Tulasi Gummadi, Ben Y. Zhang, et al. · Melanoma Research · 30

Germline genetic variation in JAK2 as a prognostic marker in castration‐resistant prostate cancer

2016 · Ben Y. Zhang, Shaun M. Riska, et al. · British Journal of Urology · 9

Management of Germ Cell Tumors

2017 · Manish Kohli, Ben Y. Zhang, et al. · Springer eBooks · 2

Works count: 8

Citation count: 608

H-index: 7

I10-index: 6